{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:16:11Z","timestamp":1794003371240,"version":"4.8.0"},"reference-count":73,"publisher":"Pacini Editore","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-n0409","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T10:40:55Z","timestamp":1597056055000},"page":"164-172","source":"Crossref","is-referenced-by-count":19,"title":["A review of the \u201cOMICS\u201d for management of patients with obstructive sleep apnoea","Una review sulle scienze OMICHE nella gestione del paziente con sindrome dell\u2019apnea ostruttiva del sonno"],"prefix":"10.14639","volume":"40","author":[{"given":"Luana","family":"Conte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Maurizio","family":"Toraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Arigliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Maffia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"De Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20340","published-online":{"date-parts":[[2020,6]]},"reference":[{"key":"10.14639\/0392-100X-N0409_ref1","doi-asserted-by":"crossref","unstructured":"Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet 2014;383:736-47. https:\/\/doi.org\/10.1016\/S0140-6736(13)60734-5","DOI":"10.1016\/S0140-6736(13)60734-5"},{"key":"10.14639\/0392-100X-N0409_ref2","doi-asserted-by":"crossref","unstructured":"Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med 2015;3:310-8. https:\/\/doi.org\/10.1016\/S2213-2600(15)00043-0","DOI":"10.1016\/S2213-2600(15)00043-0"},{"key":"10.14639\/0392-100X-N0409_ref3","doi-asserted-by":"crossref","unstructured":"Toraldo DM, Passali D, Sanna A, et al. Cost-effectiveness strategies in OSAS management: a short review. Acta Otorhinolaryngol Ital 2017;37:447-53. https:\/\/doi.org\/10.14639\/0392-100X-1520","DOI":"10.14639\/0392-100X-1520"},{"key":"10.14639\/0392-100X-N0409_ref4","doi-asserted-by":"crossref","unstructured":"Pietzsch JB, Garner A, Cipriano LE, et al. An integrated health-economic analysis of diagnostic and therapeutic strategies in the treatment of moderate-to-severe obstructive sleep apnea. Sleep 2011;34:695-709. https:\/\/doi.org\/10.5665\/SLEEP.1030","DOI":"10.5665\/SLEEP.1030"},{"key":"10.14639\/0392-100X-N0409_ref5","doi-asserted-by":"crossref","unstructured":"Tan H-L, Kheirandish-Gozal L, Gozal D. Adenotonsillectomy in pediatric OSA: time to look elsewhere. Curr Sleep Med Rep 2018;4:243-53. https:\/\/doi.org\/10.1007\/s40675-018-0122-7","DOI":"10.1007\/s40675-018-0122-7"},{"key":"10.14639\/0392-100X-N0409_ref6","doi-asserted-by":"crossref","unstructured":"Hakim F, Kheirandish-Gozal L, Gozal D. Obesity and altered sleep: a pathway to metabolic derangements in children? Semin Pediatr Neurol 2015;22:77-85. https:\/\/doi.org\/10.1016\/j.spen.2015.04.006","DOI":"10.1016\/j.spen.2015.04.006"},{"key":"10.14639\/0392-100X-N0409_ref7","doi-asserted-by":"crossref","unstructured":"Facco F, Patel S, Wolsk J, et al. Can we use home sleep testing with autoscore to triage for sleep apnea in obese pregnant women? Am J Obstet Gynecol 2018;218:S491. https:\/\/doi.org\/10.1016\/j.ajog.2017.11.358","DOI":"10.1016\/j.ajog.2017.11.358"},{"key":"10.14639\/0392-100X-N0409_ref8","doi-asserted-by":"crossref","unstructured":"Orr JE, Sands SA, Edwards BA, et al. Measuring loop gain via home sleep testing in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2018;197:1353-5. https:\/\/doi.org\/10.1164\/rccm.201707-1357LE","DOI":"10.1164\/rccm.201707-1357LE"},{"key":"10.14639\/0392-100X-N0409_ref9","doi-asserted-by":"crossref","unstructured":"Mullington JM, Abbott SM, Carroll JE, et al. Developing biomarker arrays predicting sleep and circadian-coupled risks to health. Sleep 2016;39:727-36. https:\/\/doi.org\/10.5665\/sleep.5616","DOI":"10.5665\/sleep.5616"},{"key":"10.14639\/0392-100X-N0409_ref10","doi-asserted-by":"crossref","unstructured":"Zhang H, Yang F, Guo Y, et al. The contribution of chronic intermittent hypoxia to OSAHS: from the perspective of serum extracellular microvesicle proteins. Metabolism 2018;85:97-108. https:\/\/doi.org\/10.1016\/j.metabol.2018.02.012","DOI":"10.1016\/j.metabol.2018.02.012"},{"key":"10.14639\/0392-100X-N0409_ref11","doi-asserted-by":"crossref","unstructured":"Abuyassin B, Badran M, Ayas NT, et al. Intermittent hypoxia causes histological kidney damage and increases growth factor expression in a mouse model of obstructive sleep apnea. PLoS One 2018;13:e0192084. https:\/\/doi.org\/10.1371\/journal.pone.0192084","DOI":"10.1371\/journal.pone.0192084"},{"key":"10.14639\/0392-100X-N0409_ref12","doi-asserted-by":"crossref","unstructured":"Nadeem R, Molnar J, Madbouly EM, et al. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med 2013;9:1003-12. https:\/\/doi.org\/10.5664\/jcsm.3070","DOI":"10.5664\/jcsm.3070"},{"key":"10.14639\/0392-100X-N0409_ref13","doi-asserted-by":"crossref","unstructured":"Van der Touw T, Andronicos NM, Smart N. Is C-reactive protein elevated in obstructive sleep apnea? A systematic review and meta-analysis. Biomarkers 2019;24:429-35. https:\/\/doi.org\/10.1080\/1354750X.2019.1600025","DOI":"10.1080\/1354750X.2019.1600025"},{"key":"10.14639\/0392-100X-N0409_ref14","doi-asserted-by":"crossref","unstructured":"Ayas NT, Hirsch Allen AJ, Fox N, et al. C-Reactive protein levels and the risk of incident cardiovascular and cerebrovascular events in patients with obstructive sleep apnea. Lung 2019;197:459-64. https:\/\/doi.org\/10.1007\/s00408-019-00237-0","DOI":"10.1007\/s00408-019-00237-0"},{"key":"10.14639\/0392-100X-N0409_ref15","doi-asserted-by":"crossref","unstructured":"Fleming WE, Holty J-EC, Bogan RK, et al. Use of blood biomarkers to screen for obstructive sleep apnea. Nat Sci Sleep 2018;10:159-67. https:\/\/doi.org\/10.2147\/NSS.S164488","DOI":"10.2147\/NSS.S164488"},{"key":"10.14639\/0392-100X-N0409_ref16","doi-asserted-by":"crossref","unstructured":"Aihara K, Oga T, Chihara Y, et al. Analysis of systemic and airway inflammation in obstructive sleep apnea. Sleep Breath 2013;17:597-604. https:\/\/doi.org\/10.1007\/s11325-012-0726-y","DOI":"10.1007\/s11325-012-0726-y"},{"key":"10.14639\/0392-100X-N0409_ref17","doi-asserted-by":"crossref","unstructured":"Chen YC, Chen K Den, Su MC, et al. Genome-wide gene expression array identifies novel genes related to disease severity and excessive daytime sleepiness in patients with obstructive sleep apnea. PLoS One 2017;12:e0176575. https:\/\/doi.org\/10.1371\/journal.pone.0176575","DOI":"10.1371\/journal.pone.0176575"},{"key":"10.14639\/0392-100X-N0409_ref18","doi-asserted-by":"crossref","unstructured":"Elola MT, Ferragut F, M\u00e9ndez-Huergo SP, et al. Galectins: multitask signaling molecules linking fibroblast, endothelial and immune cell programs in the tumor microenvironment. Cell Immunol 2018;333:34-45. https:\/\/doi.org\/10.1016\/J.CELLIMM.2018.03.008","DOI":"10.1016\/j.cellimm.2018.03.008"},{"key":"10.14639\/0392-100X-N0409_ref19","doi-asserted-by":"crossref","unstructured":"Moyon A, Garrigue P, Balasse L, et al. Early prediction of revascularisation by angiomotin-targeting positron emission tomography. Theranostics 2018;8:4985-94. https:\/\/doi.org\/10.7150\/thno.27728","DOI":"10.7150\/thno.27728"},{"key":"10.14639\/0392-100X-N0409_ref20","doi-asserted-by":"crossref","unstructured":"Samuel CE. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral. Virology 2011;411:180-93. https:\/\/doi.org\/10.1016\/j.virol.2010.12.004","DOI":"10.1016\/j.virol.2010.12.004"},{"key":"10.14639\/0392-100X-N0409_ref21","unstructured":"Milrad S, Mansoori N, Maidman A, et al. Adenosine Deaminase (ADA1) G22A Allele and sleep-related movement. J Clin Sleep Med 2014;1:1005."},{"key":"10.14639\/0392-100X-N0409_ref22","doi-asserted-by":"crossref","unstructured":"Henriksen EJ, Diamond-Stanic MK, Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 2011;51:993-9. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2010.12.005","DOI":"10.1016\/j.freeradbiomed.2010.12.005"},{"key":"10.14639\/0392-100X-N0409_ref23","doi-asserted-by":"crossref","unstructured":"Almendros I, Mart\u00ednez-Garc\u00eda M\u00c1, Campos-Rodr\u00edguez F, et al. Intermittent hypoxia is associated with high hypoxia inducible factor-1\u03b1 but not high vascular endothelial growth factor cell expression in tumors of cutaneous melanoma patients. Front Neurol 2018;9:272. https:\/\/doi.org\/10.3389\/fneur.2018.00272","DOI":"10.3389\/fneur.2018.00272"},{"key":"10.14639\/0392-100X-N0409_ref24","doi-asserted-by":"crossref","unstructured":"Gozal D, Ham SA, Mokhlesi B. Sleep apnea and cancer: analysis of a nationwide population sample. Sleep 2016;39:1493-500. https:\/\/doi.org\/10.5665\/sleep.6004","DOI":"10.5665\/sleep.6004"},{"key":"10.14639\/0392-100X-N0409_ref25","doi-asserted-by":"crossref","unstructured":"Gozal D, Farr\u00e9 R, Nieto FJ. Obstructive sleep apnea and cancer: epidemiologic links and theoretical biological constructs. Sleep Med Rev 2016;27:43-55. https:\/\/doi.org\/10.1016\/J.SMRV.2015.05.006","DOI":"10.1016\/j.smrv.2015.05.006"},{"key":"10.14639\/0392-100X-N0409_ref26","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, Campos-Rodriguez F, Barb\u00e9 F. Cancer and OSA: current evidence from human studies. Chest 2016;150:451-63. https:\/\/doi.org\/10.1016\/J.CHEST.2016.04.029","DOI":"10.1016\/j.chest.2016.04.029"},{"key":"10.14639\/0392-100X-N0409_ref27","doi-asserted-by":"crossref","unstructured":"Hunyor I, Cook KM. Models of intermittent hypoxia and obstructive sleep apnea: molecular pathways and their contribution to cancer. Am J Physiol Regul Integr Comp Physiol 2018;315:R669-87. https:\/\/doi.org\/10.1152\/ajpregu.00036.2018","DOI":"10.1152\/ajpregu.00036.2018"},{"key":"10.14639\/0392-100X-N0409_ref28","doi-asserted-by":"crossref","unstructured":"Drager LF, Genta PR, Pedrosa RP, et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 2010;105:1135-9. https:\/\/doi.org\/10.1016\/j.amjcard.2009.12.017","DOI":"10.1016\/j.amjcard.2009.12.017"},{"key":"10.14639\/0392-100X-N0409_ref29","doi-asserted-by":"crossref","unstructured":"Khalyfa A, Kheirandish-Gozal L, Gozal D. Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity. Respir Physiol Neurobiol 2018;256:143-56. https:\/\/doi.org\/10.1016\/J.RESP.2017.06.004","DOI":"10.1016\/j.resp.2017.06.004"},{"key":"10.14639\/0392-100X-N0409_ref30","doi-asserted-by":"crossref","unstructured":"Zheng H, Li R, Zhang J, et al. Salivary biomarkers indicate obstructive sleep apnea patients with cardiovascular diseases. Sci Rep 2014;4:7046. https:\/\/doi.org\/10.1038\/srep07046","DOI":"10.1038\/srep07046"},{"key":"10.14639\/0392-100X-N0409_ref31","doi-asserted-by":"crossref","unstructured":"Barcel\u00f3 A, Pi\u00e9rola J, Esquinas C, et al. Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea. Eur Respir J 2012;40:1046-8. https:\/\/doi.org\/10.1183\/09031936.00011912","DOI":"10.1183\/09031936.00011912"},{"key":"10.14639\/0392-100X-N0409_ref32","doi-asserted-by":"crossref","unstructured":"Dyugovskaya L, Polyakov A, Ginsberg D, et al. Molecular pathways of spontaneous and TNF-\u03b1 - mediated neutrophil apoptosis under intermittent hypoxia. Am J Respir Cell Mol Biol 2011;45:154-62. https:\/\/doi.org\/10.1165\/rcmb.2010-0025OC","DOI":"10.1165\/rcmb.2010-0025OC"},{"key":"10.14639\/0392-100X-N0409_ref33","doi-asserted-by":"crossref","unstructured":"Jurado-Gamez B, Gomez-Chaparro JL. Serum proteomic changes in adults with obstructive sleep apnoea. J Sleep Res 2012;21:139-46. https:\/\/doi.org\/10.1111\/j.1365-2869.2011.00955.x","DOI":"10.1111\/j.1365-2869.2011.00955.x"},{"key":"10.14639\/0392-100X-N0409_ref34","doi-asserted-by":"crossref","unstructured":"Ferrarini A, Rup\u00e9rez FJ, Erazo M, et al. Fingerprinting-based metabolomic approach with LC-MS to sleep apnea and hypopnea syndrome: A pilot study. Electrophoresis 2013;34:2873-81. https:\/\/doi.org\/10.1002\/elps.201300081","DOI":"10.1002\/elps.201300081"},{"key":"10.14639\/0392-100X-N0409_ref35","doi-asserted-by":"crossref","unstructured":"Lebkuchen A, Carvalho VM, Venturini G, et al. Metabolomic and lipidomic profile in men with obstructive sleep apnoea: implications for diagnosis and biomarkers of cardiovascular risk. Sci Rep 2018;8:11270. https:\/\/doi.org\/10.1038\/s41598-018-29727-6","DOI":"10.1038\/s41598-018-29727-6"},{"key":"10.14639\/0392-100X-N0409_ref36","doi-asserted-by":"crossref","unstructured":"Kawai M, Kirkness JP, Yamamura S, et al. Increased phosphatidylcholine concentration in saliva reduces surface tension and improves airway patency in obstructive sleep apnoea. J Oral Rehabil 2013;40:758-66. https:\/\/doi.org\/10.1111\/joor.12094","DOI":"10.1111\/joor.12094"},{"key":"10.14639\/0392-100X-N0409_ref37","doi-asserted-by":"crossref","unstructured":"Engeli S, Bl\u00fcher M, Jumpertz R, et al. Circulating anandamide and blood pressure in patients with obstructive sleep apnea. J Hypertens 2012;30:2345-51. https:\/\/doi.org\/10.1097\/HJH.0b013e3283591595","DOI":"10.1097\/HJH.0b013e3283591595"},{"key":"10.14639\/0392-100X-N0409_ref38","doi-asserted-by":"crossref","unstructured":"Papandreou C. Independent associations between fatty acids and sleep quality among obese patients with obstructive sleep apnoea syndrome. J Sleep Res 2013;22:569-72. https:\/\/doi.org\/10.1111\/jsr.12043","DOI":"10.1111\/jsr.12043"},{"key":"10.14639\/0392-100X-N0409_ref39","doi-asserted-by":"crossref","unstructured":"Ezzedini R, Darabi M, Ghasemi B, et al. Tissue fatty acid composition in obstructive sleep apnea and recurrent tonsillitis. Int J Pediatr Otorhinolaryngol 2013;77:1008-12. https:\/\/doi.org\/10.1016\/j.ijporl.2013.03.033","DOI":"10.1016\/j.ijporl.2013.03.033"},{"key":"10.14639\/0392-100X-N0409_ref40","doi-asserted-by":"crossref","unstructured":"Valaiyapathi B, Calhoun DA. Role of mineralocorticoid receptors in obstructive sleep apnea and metabolic syndrome. Curr Hypertens Rep 2018;20:23. https:\/\/doi.org\/10.1007\/s11906-018-0819-5","DOI":"10.1007\/s11906-018-0819-5"},{"key":"10.14639\/0392-100X-N0409_ref41","doi-asserted-by":"crossref","unstructured":"Pagotto U, Vicennati V, Pasquali R. Il sistema endocannabinoide e il controllo del metabolismo energetico: fisiologia e fisiopatologia. G Ital Cardiol 2008;9(Suppl 1-4):74S-82S.","DOI":"10.1007\/BF03344556"},{"key":"10.14639\/0392-100X-N0409_ref42","doi-asserted-by":"crossref","unstructured":"Khalyfa A, Gozal D. Connexins and atrial fibrillation in obstructive sleep apnea. Curr Sleep Med Rep 2018;4:300-11. https:\/\/doi.org\/10.1007\/s40675-018-0130-7","DOI":"10.1007\/s40675-018-0130-7"},{"key":"10.14639\/0392-100X-N0409_ref43","doi-asserted-by":"crossref","unstructured":"Park AJ, Bloom SR. Neuroendocrine control of food intake. Curr Opin Gastroenterol 2005;21:228-33. https:\/\/doi.org\/10.1097\/01.mog.0000153358.05901.3f","DOI":"10.1097\/01.mog.0000153358.05901.3f"},{"key":"10.14639\/0392-100X-N0409_ref44","doi-asserted-by":"crossref","unstructured":"Di Marzo V, Matias I. Endocannabinoid control of food intake and energy balance. Nat Neurosci 2005;8:585-9. https:\/\/doi.org\/10.1038\/nn1457","DOI":"10.1038\/nn1457"},{"key":"10.14639\/0392-100X-N0409_ref45","doi-asserted-by":"crossref","unstructured":"Paci A, Marrone O, Lenzi S, et al. Endogenous digitalislike factors in obstructive sleep apnea. Hypertens Res 2000;23:S87-91. https:\/\/doi.org\/10.1291\/hypres.23.Supplement_S87","DOI":"10.1291\/hypres.23.Supplement_S87"},{"key":"10.14639\/0392-100X-N0409_ref46","doi-asserted-by":"crossref","unstructured":"Nonaka-Sarukawa M, Yamamoto K, Aoki H, et al. Increased urinary 15-F 2t-isoprostane concentrations in patients with non-ischaemic congestive heart failure: a marker of oxidative stress. Heart 2003;89:871-4. https:\/\/doi.org\/10.1136\/heart.89.8.871","DOI":"10.1136\/heart.89.8.871"},{"key":"10.14639\/0392-100X-N0409_ref47","doi-asserted-by":"crossref","unstructured":"Dikmeno\u011flu N, Cift\u00e7i B, Ileri E, et al. Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome. Sleep Med 2006;7:255-61. https:\/\/doi.org\/10.1016\/j.sleep.2005.12.005","DOI":"10.1016\/j.sleep.2005.12.005"},{"key":"10.14639\/0392-100X-N0409_ref48","unstructured":"Gawe\u0142 S, Wardas M, Niedworok E, et al. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek 2004;57:453-5."},{"key":"10.14639\/0392-100X-N0409_ref49","doi-asserted-by":"crossref","unstructured":"Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res 1999;424:83-95. https:\/\/doi.org\/10.1016\/s0027-5107(99)00010-x","DOI":"10.1016\/S0027-5107(99)00010-X"},{"key":"10.14639\/0392-100X-N0409_ref50","doi-asserted-by":"crossref","unstructured":"Xu H, Zheng X, Qian Y, et al. Metabolomics profiling for obstructive sleep apnea and simple snorers. Sci Rep 2016;6:30958. https:\/\/doi.org\/10.1038\/srep30958","DOI":"10.1038\/srep30958"},{"key":"10.14639\/0392-100X-N0409_ref51","doi-asserted-by":"crossref","unstructured":"Stanke-Labesque F, B\u00e4ck M, Lefebvre B, et al. Increased urinary leukotriene E4 excretion in obstructive sleep apnea: effects of obesity and hypoxia. J Allergy Clin Immunol 2009;124:364-70, 370.e1-2. https:\/\/doi.org\/10.1016\/j.jaci.2009.05.033","DOI":"10.1016\/j.jaci.2009.05.033"},{"key":"10.14639\/0392-100X-N0409_ref52","doi-asserted-by":"crossref","unstructured":"Gautier-Veyret E, B\u00e4ck M, Arnaud C, et al. Cysteinyl-leukotriene pathway as a new therapeutic target for the treatment of atherosclerosis related to obstructive sleep apnea syndrome. Pharmacol Res 2018;134:311-9. https:\/\/doi.org\/10.1016\/j.phrs.2018.06.014","DOI":"10.1016\/j.phrs.2018.06.014"},{"key":"10.14639\/0392-100X-N0409_ref53","doi-asserted-by":"crossref","unstructured":"Zaffanello M, Bilimler C, Hekimligi D, et al. Relationship between plasma homocysteine and obstructive sleep apneas in children: a preliminary study. EJMO 2018;2:130-4. https:\/\/doi.org\/10.14744\/ejmo.2018.93685","DOI":"10.14744\/ejmo.2018.93685"},{"key":"10.14639\/0392-100X-N0409_ref54","doi-asserted-by":"crossref","unstructured":"Curr\u00f2 M, Gugliandolo A, Gangemi C, et al. Toxic effects of mildly elevated homocysteine concentrations in neuronal-like cells. Neurochem Res 2014;39:1485-95. https:\/\/doi.org\/10.1007\/s11064-014-1338-7","DOI":"10.1007\/s11064-014-1338-7"},{"key":"10.14639\/0392-100X-N0409_ref55","doi-asserted-by":"crossref","unstructured":"Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J 2015;14:6. https:\/\/doi.org\/10.1186\/1475-2891-14-6","DOI":"10.1186\/1475-2891-14-6"},{"key":"10.14639\/0392-100X-N0409_ref56","doi-asserted-by":"crossref","unstructured":"Kim J, Lee SK, Yoon DW, et al. Concurrent presence of obstructive sleep apnea and elevated homocysteine levels exacerbate the development of hypertension: a KoGES Six-year follow-up study. Sci Rep 2018;8:2665. https:\/\/doi.org\/10.1038\/s41598-018-21033-5","DOI":"10.1038\/s41598-018-21033-5"},{"key":"10.14639\/0392-100X-N0409_ref57","doi-asserted-by":"crossref","unstructured":"Baszczuk A, Kopczy\u0144ski Z. Hyperhomocysteinemia in patients with cardiovascular disease. Postepy Hig Med Dosw 2014;68:579-89. https:\/\/doi.org\/10.5604\/17322693.1102340","DOI":"10.5604\/17322693.1102340"},{"key":"10.14639\/0392-100X-N0409_ref58","doi-asserted-by":"crossref","unstructured":"Pang X, Liu J, Zhao J, et al. Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-\u03baB signal pathway in rat vascular smooth muscle cells. Atherosclerosis 2014;236:73-81. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.06.021","DOI":"10.1016\/j.atherosclerosis.2014.06.021"},{"key":"10.14639\/0392-100X-N0409_ref59","doi-asserted-by":"crossref","unstructured":"Kaminska M, Mery VP, Lafontaine A-L, et al. Change in cognition and other non-motor symptoms with obstructive sleep apnea treatment in Parkinson disease. J Clin Sleep Med 2018;14:819-28. https:\/\/doi.org\/10.5664\/jcsm.7114","DOI":"10.5664\/jcsm.7114"},{"key":"10.14639\/0392-100X-N0409_ref60","doi-asserted-by":"crossref","unstructured":"Fletcher EC, Miller J, Schaaf JW, et al. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987;10:35-44. https:\/\/doi.org\/10.1093\/sleep\/10.1.35","DOI":"10.1093\/sleep\/10.1.35"},{"key":"10.14639\/0392-100X-N0409_ref61","doi-asserted-by":"crossref","unstructured":"Paik M-J, Kim D-K, Nguyen D-T, et al. Correlation of daytime sleepiness with urine metabolites in patients with obstructive sleep apnea. Sleep Breath 2014;18:517-23. https:\/\/doi.org\/10.1007\/s11325-013-0913-5","DOI":"10.1007\/s11325-013-0913-5"},{"key":"10.14639\/0392-100X-N0409_ref62","doi-asserted-by":"crossref","unstructured":"O\u2019Driscoll DM, Horne RSC, Davey MJ, et al. Increased sympathetic activity in children with obstructive sleep apnea: cardiovascular implications. Sleep Med 2011;12:483-8. https:\/\/doi.org\/10.1016\/j.sleep.2010.09.015","DOI":"10.1016\/j.sleep.2010.09.015"},{"key":"10.14639\/0392-100X-N0409_ref63","doi-asserted-by":"crossref","unstructured":"Gislason T, Hedner J, Terenius L, et al. Substance P, thyrotropin-releasing hormone, and monoamine metabolites in cerebrospinal fluid in sleep apnea patients. Am Rev Respir Dis 1992;146:784-6. https:\/\/doi.org\/10.1164\/ajrccm\/146.3.784","DOI":"10.1164\/ajrccm\/146.3.784"},{"key":"10.14639\/0392-100X-N0409_ref64","doi-asserted-by":"crossref","unstructured":"Krishna J, Shah ZA, Merchant M, et al. Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med 2006;7:221-7. https:\/\/doi.org\/10.1016\/j.sleep.2005.09.010","DOI":"10.1016\/j.sleep.2005.09.010"},{"key":"10.14639\/0392-100X-N0409_ref65","doi-asserted-by":"crossref","unstructured":"Shah ZA, Jortani SA, Tauman R, et al. Serum proteomic patterns associated with sleep-disordered breathing in children. Pediatr Res 2006;59:466-70. https:\/\/doi.org\/10.1203\/01.pdr.0000198817.35627.fc","DOI":"10.1203\/01.pdr.0000198817.35627.fc"},{"key":"10.14639\/0392-100X-N0409_ref66","doi-asserted-by":"crossref","unstructured":"Gozal D, Jortani S, Snow AB, et al. Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med 2009;180:1253-61. https:\/\/doi.org\/:10.1164\/rccm.200905-0765OC","DOI":"10.1164\/rccm.200905-0765OC"},{"key":"10.14639\/0392-100X-N0409_ref67","doi-asserted-by":"crossref","unstructured":"Seetho IW, Siwy J, Albalat A, et al. Urinary proteomics in obstructive sleep apnoea and obesity. Eur J Clin Invest 2014;44:1104-15. https:\/\/doi.org\/10.1111\/eci.12346","DOI":"10.1111\/eci.12346"},{"key":"10.14639\/0392-100X-N0409_ref68","doi-asserted-by":"crossref","unstructured":"Lavie L. Intermittent hypoxia and obstructive sleep apnea: mechanisms, interindividual responses and clinical insights. In: Fabian Z, editor. Hypoxia. London: IntechOpen; 2019. https:\/\/doi.org\/10.5772\/intechopen.86117","DOI":"10.5772\/intechopen.86117"},{"key":"10.14639\/0392-100X-N0409_ref69","doi-asserted-by":"crossref","unstructured":"Chen Y-C, Chen K-D, Su M-C, et al. Genome-wide gene expression array identifies novel genes related to disease severity and excessive daytime sleepiness in patients with obstructive sleep apnea. PLoS One 2017;12:e0176575. https:\/\/doi.org\/10.1371\/journal.pone.0176575","DOI":"10.1371\/journal.pone.0176575"},{"key":"10.14639\/0392-100X-N0409_ref70","doi-asserted-by":"crossref","unstructured":"Becker L, Kheirandish-Gozal L, Peris E, et al. Contextualised urinary biomarker analysis facilitates diagnosis of paediatric obstructive sleep apnoea. Sleep Med 2014;15:541-9. https:\/\/doi.org\/10.1016\/j.sleep.2014.01.010","DOI":"10.1016\/j.sleep.2014.01.010"},{"key":"10.14639\/0392-100X-N0409_ref71","doi-asserted-by":"crossref","unstructured":"Arigliani M, Toraldo DM, Montevecchi F, et al. A new technological advancement of the drug-induced sleep endoscopy (DISE) procedure: The \u201cAll in One Glance\u201d Strategy. Int J Environ Res Public Health 2020;17:4261. https:\/\/doi.org\/10.3390\/ijerph17124261","DOI":"10.3390\/ijerph17124261"},{"key":"10.14639\/0392-100X-N0409_ref72","doi-asserted-by":"crossref","unstructured":"Vicini C, Colabianchi V, Marrano GG, et al. Description of the relationship between NOHL classification in drug-induced sleep endoscopy and initial AHI in patients with moderate to severe OSAS, and evaluation of the results obtained with oral appliance therapy. Acta Otorhinolaryngol Ital 2020;40:50-6. https:\/\/doi.org\/10.14639\/0392-100X-2290","DOI":"10.14639\/0392-100X-2290"},{"key":"10.14639\/0392-100X-N0409_ref73","doi-asserted-by":"crossref","unstructured":"Salamanca F, Leone F, Bianchi A, et al. Surgical treatment of epiglottis collapse in obstructive sleep apnoea syndrome: Epiglottis stiffening operation. Acta Otorhinolaryngol Ital 2019;39:404-8. https:\/\/doi.org\/10.14639\/0392-100X-N0287","DOI":"10.14639\/0392-100X-N0287"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T07:16:12Z","timestamp":1729667772000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.actaitalica.it\/article\/view\/409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":73,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,6]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-n0409","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6]]},"article-number":"2"}}